Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis

CAR-T therapy has revolutionized the treatment of relapsed/refractory B-cell malignancies. Patients who are receiving such therapy are susceptible to an increased incidence of infections due to post-treatment immunosuppression. The need for antifungal prophylaxis during the period of neutropenia rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Pennese, Elsa, Salutari, Prassede, Carriero, Luigi, Restuccia, Francesco, De Filippis, Antonio Fabio, De Luca, Giulia, Giancola, Raffaella, Guardalupi, Francesco, Corradi, Giulia, Fabi, Bianca, Baldoni, Stefano, Di Ianni, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574963/
https://www.ncbi.nlm.nih.gov/pubmed/37841271
http://dx.doi.org/10.3389/fimmu.2023.1272798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574963/
https://www.ncbi.nlm.nih.gov/pubmed/37841271
http://dx.doi.org/10.3389/fimmu.2023.1272798

Ejemplares similares